SF 2852 modifies Minnesota's optometry scope of practice by adding specific restrictions to optometrists' authority. It directly affects licensed optometrists in Minnesota by limiting their ability to prescribe or administer certain medications and treatments. The bill explicitly prohibits: administering prescription drugs via IV/IM/injection (except for anaphylaxis), performing invasive surgery (including laser procedures), prescribing Schedule II/III oral drugs or steroids, prescribing oral antivirals beyond 10 days, and prescribing oral carbonic anhydrase inhibitors beyond 7 days. These changes clarify the boundaries of optometric practice under existing law. The bill does not expand optometrists' authority but defines specific limitations on their current scope.
HF 2765 modifies Minnesota's optometry scope of practice by adding specific restrictions to the existing law. The bill directly affects licensed optometrists by prohibiting them from administering prescription medications via injection (except for anaphylaxis treatment), performing invasive surgeries (including laser procedures), prescribing certain strong oral medications (like Schedule II/III drugs or steroids), and extending the duration of some prescriptions (limiting oral antivirals to 10 days and oral carbonic anhydrase inhibitors to 7 days). These changes clarify the boundaries of optometric practice under Minnesota Statutes 148.56. The bill does not alter optometrists' core duties like vision testing, lens prescribing, or diagnosing eye conditions.
